Insmed | INSM - Capital Social Ordinario

Precio De Mercado
145.11
Cambio Diario
0.51 0.35%
Mensual
-3.59%
Anual
86.59%
Q1 Expectativa
135.29




Capital Social Ordinario Cambio Fecha
BioMarin Pharmaceutical USD 192.3M 201K 2025-12
Cytokinetics USD 122.26M 145K 2025-12
DBV Technologies USD 11.65M 1000 2025-03
Gilead Sciences USD 1.24B 1000K 2025-12
Heron Therapeutics USD 188.31M 4.99M 2025-12
Insmed USD 214.26M 1.67M 2025-12
Novartis USD 1.92B 17.06M 2025-09
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Sarepta Therapeutics USD 104.96M 196K 2025-12
Ultragenyx Pharmaceutical USD 96.44M 88K 2025-09
Vertex Pharmaceuticals USD 254M 0 2025-12